Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

William J. Sandborn, Joshua Korzenik, Bret Lashner, Jonathan A. Leighton, Uma Mahadevan, James F. Marion, Michael Safdi, Charles A. Sninsky, Raman M. Patel, Keith A. Friedenberg, Preston Dunnmon, David Ramsey, Sunanda Kane

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences